Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-15-005936
Filing Date
2015-04-17
Accepted
2015-04-17 13:28:47
Documents
1
Period of Report
2015-04-15

Document Format Files

Seq Description Document Type Size
1 rrd424360.html 4  
1 rrd424360.xml 4 3922
  Complete submission text file 0001181431-15-005936.txt   5406
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MEADOWLANDS PLAZA EAST RUTHERFORD NJ 07073
Business Address
Yanai Shlomo (Reporting) CIK: 0001562645 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 15777314